The study found that taking Zepbound or another GLP-1 drug had little to no impact on someones risk of breast, kidney, thyroid, and pancreatic cancers. The drug did not appear to affect someones risk for eight other types of obesity-related cancers
The companys lead candidate (NPI-001), manufactured using a patented process, is the amide form of N-acetyl-L-cysteine (NAC)
These observations were performed by three independent physiatrists who were blinded to the treatment groups, ensuring unbiased assessment
Interactions with Medications: Inform your healthcare provider of any supplements you are taking to avoid potential interactions
it can cause numbness, tingling, and pain in the hands and feet due to such damage
Discontinue use if you experience any unusual symptoms and consult a healthcare professional